Skip to content
Data Dive Into NK-1 Antagonists & Carboplatin episode artwork

Nov 7, 2019 17 min

Data Dive Into NK-1 Antagonists & Carboplatin

from OncoPharm Hosted by John Bossaer

ASCO's updated 2017 antiemetic guidelines recommend NK-1 antagonists to prevent CINV with standard Q 3 week carboplatin (i.e. AUC 5-6), but how good are the data to support that? We dive into the supporting data.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Data Dive Into NK-1 Antagonists & Carboplatin

0:00 17:02

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 17 minutes long.

When was this OncoPharm episode published?

This episode was published on November 7, 2019.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.